In a report released yesterday, Elizabeth Anderson CFA from Evercore ISI maintained a Buy rating on Icon (ICLR – Research Report), with a price ...

RBC Capital analyst Sean Dodge maintained a Buy rating on Icon (ICLR – Research Report) yesterday and set a price target of $263.00. The ...

ICON (NASDAQ:ICLR) stock fell 8% early Tuesday after it issued financial guidance for 2025. The clinical research ...

Fiduciary Management Inc. (FMI), an independent money management firm, released its “FMI International Equity Strategy ...

ICON forecasts 2025 revenue at $8.05 billion–$8.65 billion and adjusted EPS of $13.00–$15.00, citing biopharma spending cuts ...

Full year 2025 revenue guidance in the range of $8,050 - $8,650 million; midpoint of $8,350 million representing growth of ...

The Edge specializes in special situations such as corporate break ups. Its founder Jim Osman wants Boeing to go to pieces.

ICON Equity Fund earns an Average Process Pillar ... Analyzing additional factors, this strategy continually held some stocks with low trading volume over the last few years.

TOKYO (AP) — Asian shares mostly rose Thursday, following a rally on Wall Street driven by encouraging update on U.S.

Benchmark maintains its buy rating on MSTR with a price target of $650. As of Monday, MicroStrategy purchased a further 2,530 ...

Asian stocks are mixed after Wall Street’s mostly positive performance ahead of key U.S. inflation data that could influence ...

The stock price for Israeli liner company Zim lost ground for a ninth consecutive day on Wednesday after a ceasefire and ...